Watch for Adtralza and Rinvoq for Eczema

March 2022

You'll notice more meds for eczema trying to squeeze into the market...including Adtralza and Rinvoq.

Adtralza (tralokinumab) is an injectable "monoclonal antibody"...similar to Dupixent (dupilumab).

Rinvoq (upadacitinib) is an oral "Janus kinase (JAK) inhibitor."

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Double Down on Preventing Errors With "Two-for-One" Meds
Insomnia Put Mix-Ups With Melatonin to Rest
Ophthalmology Be Ready to Dispense Cequa for Dry Eyes
Mental Health Stay Alert for Suicide Warning Signs in Patients and Colleagues
Sleep Disorders Wakix Will Be a New Rx Med for Narcolepsy
Oral Health Listen for Dental Problems With Buccal or Sublingual Buprenorphine
Neurology & Pain Know How Meds for Diabetic Neuropathy Stack Up
Eczema Watch for Adtralza and Rinvoq for Eczema
Corticosteroids Help Prevent Mishaps With Steroid Tapers